LAS VEGAS, Sept. 7 /PRNewswire-FirstCall/ -- LifeQuest World Corporation (BULLETIN BOARD: LQWC) is proud to announce that they will be contributing on an ongoing basis to the Dietary Supplement Education Alliance (DSEA).
DSEA is a coalition of industry leaders whose mission is to educate consumers, media and policymakers on the benefits of dietary supplements for optimizing health and prevention of disease, with a focus on their safety, efficacy and regulation. In addition to media outreach, DSEA has produced a Web site, http://www.supplementinfo.org/, which has become a well-known resource for objective information about nutritional supplements accessed on an ongoing basis by media, consumers, health professionals and legislators.
The Scientific Advisory Board members are leaders in the industry and include Ph.D.'s, Research Chemists and others with prominent positions in major Universities.
LifeQuest is pleased to support DSEA's commitment to ensuring that consumers, the media, health professionals, and policymakers have the complete facts about dietary supplements.
About LifeQuest World Corporation Inc.
LifeQuest World Corporation Inc. is a life science company focused on the global commercialization of unique, patented and scientifically proven natural-source health products that allow a proactive health management approach by delivering the highest levels of effectiveness, safety, and prevention.
LifeQuest's new, patented extract, developed by leading research scientists at the National Center for Natural Products Research (NCNPR) at the University of Mississippi, "... is one of the most promising projects our Center has produced in recent years, including its intellectual property," says Dr. Walter G. Chambliss, Director of Technology Management at the University of Mississippi. "Our research has shown that this extract is the most powerful, natural immune-stimulatory dietary supplement discovered to date with respect to macrophage activation," says Dr. David Pasco, Assistant Director at NCNPR. The results of this research were published in Planta Medica (Pugh et al, 2001 67(8): 737-742).
The statements in the press release that relate to the company's expectations with regard to the future impact on the company's results from new products or actions in development are forward-looking statements, within the meaning of the Private Securities Litigation Reform Act of 1995. The statements in this document may also contain "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Since this information may contain statements that involve risk and uncertainties and are subject to change at any time, the company's actual results may differ materially from expected results.
